[go: up one dir, main page]

ECSP12012102A - Proceso para producir un extracto de alérgenos - Google Patents

Proceso para producir un extracto de alérgenos

Info

Publication number
ECSP12012102A
ECSP12012102A ECSP12012102A ECSP12012102A EC SP12012102 A ECSP12012102 A EC SP12012102A EC SP12012102 A ECSP12012102 A EC SP12012102A EC SP12012102 A ECSP12012102 A EC SP12012102A
Authority
EC
Ecuador
Prior art keywords
produce
extract
allergens
allergens extract
allergy
Prior art date
Application number
Other languages
English (en)
Inventor
Sánchez Jerónimo Carnes
Original Assignee
Leti S L Unipersonal Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leti S L Unipersonal Lab filed Critical Leti S L Unipersonal Lab
Publication of ECSP12012102A publication Critical patent/ECSP12012102A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención se refiere a un proceso para producir un extracto de alérgenos purificado y a composiciones farmacéuticas y vacunas para su uso en el diagnóstico y tratamiento de la alergia.
ECSP12012102 2010-02-12 2012-08-09 Proceso para producir un extracto de alérgenos ECSP12012102A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201030199 2010-02-12

Publications (1)

Publication Number Publication Date
ECSP12012102A true ECSP12012102A (es) 2013-04-30

Family

ID=43760024

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP12012102 ECSP12012102A (es) 2010-02-12 2012-08-09 Proceso para producir un extracto de alérgenos

Country Status (17)

Country Link
US (3) US9884111B2 (es)
EP (2) EP2533808B1 (es)
JP (3) JP5969922B2 (es)
CN (2) CN102821785B (es)
AU (1) AU2011214316B2 (es)
BR (1) BR112012019848B1 (es)
CA (2) CA3060638A1 (es)
CL (1) CL2012002246A1 (es)
CO (1) CO6602140A2 (es)
EC (1) ECSP12012102A (es)
ES (2) ES2395093T3 (es)
MX (1) MX2012009267A (es)
PE (1) PE20130044A1 (es)
PL (2) PL2533808T3 (es)
PT (2) PT2853271T (es)
RU (2) RU2706685C2 (es)
WO (1) WO2011098569A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395093T3 (es) 2010-02-12 2014-12-22 Laboratorios Leti, S.L. Proceso para producir un extracto de alérgenos
LT2875828T (lt) * 2012-07-20 2019-07-25 Diater, Laboratorio de Diagnostico y Aplicaciones TerapĆ©uticas, S.A. Kompozicijos, skirtos polimerintų alergenų intraderminiam įvedimui
CN104447943A (zh) * 2014-11-21 2015-03-25 浙江我武生物科技股份有限公司 一种提取狗毛皮屑变应原的方法
US20210085782A1 (en) * 2017-07-31 2021-03-25 Laboratorios Leti S.L. Unipersonal Veterinary product
US11408895B1 (en) 2018-04-09 2022-08-09 Hob Biotech Group Corp., Ltd. Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay
EP3911343A1 (en) * 2019-01-17 2021-11-24 Leti Pharma S.L. Methods of purifying an allergen extract
CN113817037A (zh) * 2021-10-29 2021-12-21 南昌大学 一种从生腰果中制备高纯度致敏原Ana o 3的方法
CN115032406A (zh) * 2022-07-04 2022-09-09 郑州安图生物工程股份有限公司 检测试剂及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463740A (en) 1946-03-29 1949-03-08 Raymond S Burnett Preparation of peanut protein free from peanut skin pigment
GB1283989A (en) * 1969-12-15 1972-08-02 Omega Lab Ltd Allergenic extracts and method for their preparation
US4234569A (en) * 1978-10-04 1980-11-18 The Johns Hopkins University Production of aldehyde-treated allergen-containing substances
JPS5645417A (en) 1979-09-19 1981-04-25 Mochida Pharmaceut Co Ltd Pharmaceutical composition having antiallergic activity
EP0083497A3 (en) 1982-01-06 1985-11-06 Beecham Group Plc Process for preparing modified allergens, their use in treating allergic conditions
US4716120A (en) * 1983-03-17 1987-12-29 Minnesota Mining And Manufacturing Company Stable allergenic extracts and methods
ES2013359A6 (es) * 1988-11-04 1990-05-01 Corporacion Biolog Farmaceutic Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.
EP0582672A4 (en) * 1991-04-26 1994-06-29 Emanuel Calenoff Methods to detect and treat diseases caused by bacterial allergens
ATE148708T1 (de) 1992-09-21 1997-02-15 Leti Lab Verfahren zur reinigung von waessrigen extrakten, die allergenische proteine enthalten, so erhaltene extrakte und ihre verwendung
WO1994006821A1 (en) * 1992-09-21 1994-03-31 Laboratorios Leti S.A. A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
EP1360297A2 (en) 2001-02-05 2003-11-12 The Regents Of The University Of California Ragweed allergens
EP1380589A4 (en) * 2001-03-09 2004-09-01 Chugai Pharmaceutical Co Ltd PROTEIN CLEANING METHOD
RU2205661C2 (ru) * 2001-07-13 2003-06-10 Петров Рем Викторович Аллерготропин для лечения полинозов и способ лечения полинозов
CN1430052A (zh) * 2001-12-31 2003-07-16 合富生化科技股份有限公司 过敏原检测芯片
FR2841906B1 (fr) * 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
BRPI0406470A (pt) * 2003-01-09 2005-12-06 Genentech Inc Método para a purificação de polipeptìdeo heterólogo e caldo ou homogeneizado de fermentação
ES2247433T3 (es) * 2003-01-21 2006-03-01 Biomay Produktions- Und Handels- Aktiengesellschaft Procedimiento para la preparacion de proteinas de mosaico hipoalergenicas.
EP1834649A1 (en) 2006-03-14 2007-09-19 Alk-Abello A/S Method of developing a process for producing an allergen extract
DK1834648T3 (da) * 2006-03-14 2013-11-04 Alk Abello As Fremgangsmåde til fremstilling af et allergenekstrakt
US7887821B2 (en) * 2007-12-20 2011-02-15 Alk-Abello A/S Process for producing an allergen extract
ES2395093T3 (es) * 2010-02-12 2014-12-22 Laboratorios Leti, S.L. Proceso para producir un extracto de alérgenos

Also Published As

Publication number Publication date
PL2853271T3 (pl) 2018-09-28
US20180200363A1 (en) 2018-07-19
PL2533808T3 (pl) 2015-03-31
RU2012134032A (ru) 2014-03-20
EP2533808A1 (en) 2012-12-19
EP2533808B1 (en) 2014-08-20
EP2853271B1 (en) 2018-04-04
US11246923B2 (en) 2022-02-15
CO6602140A2 (es) 2013-01-18
JP6646480B2 (ja) 2020-02-14
CA2789174C (en) 2021-08-24
AU2011214316A1 (en) 2012-08-16
CN104371016B (zh) 2018-05-15
US9884111B2 (en) 2018-02-06
CN104371016A (zh) 2015-02-25
MX2012009267A (es) 2013-02-07
RU2015149538A (ru) 2019-01-15
CN102821785B (zh) 2014-12-10
PT2533808E (pt) 2014-11-28
CL2012002246A1 (es) 2013-05-24
WO2011098569A9 (en) 2012-03-15
BR112012019848B1 (pt) 2022-03-15
EP2853271A1 (en) 2015-04-01
JP2013519656A (ja) 2013-05-30
RU2015149538A3 (es) 2019-05-08
RU2572230C2 (ru) 2015-12-27
JP5969922B2 (ja) 2016-08-17
ES2395093T3 (es) 2014-12-22
RU2706685C2 (ru) 2019-11-20
US20180200362A1 (en) 2018-07-19
JP2016145235A (ja) 2016-08-12
PE20130044A1 (es) 2013-02-14
CN102821785A (zh) 2012-12-12
WO2011098569A1 (en) 2011-08-18
CA2789174A1 (en) 2011-08-18
ES2676058T3 (es) 2018-07-16
CA3060638A1 (en) 2011-08-18
JP2017226687A (ja) 2017-12-28
AU2011214316B2 (en) 2015-07-02
ES2395093T1 (es) 2013-02-08
PT2853271T (pt) 2018-07-09
BR112012019848A2 (pt) 2020-07-07
US20150306211A1 (en) 2015-10-29

Similar Documents

Publication Publication Date Title
ECSP12012102A (es) Proceso para producir un extracto de alérgenos
DOP2018000203A (es) Profármaco de adrenomedulina basado en polietilenglicol y su uso
LT3444261T (lt) Metilbardoksolono 2,2-difluorpropionamido darinys, jo farmacinės kompozicijos ir polimorfai, skirti panaudoti tam tikrų ligų gydymui
MX345697B (es) Formulaciones de rifaximina y usos de las mismas.
MX353827B (es) Formas de rifaximina y usos de la misma.
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
AR089993A1 (es) Macrociclos peptidomimeticos
MX2015003140A (es) Formulaciones de enzalutamida.
CO6680687A2 (es) Inmunoglobinas con dominio variable dual capaces de unirse a il 1 beta e il-17, composiciones farmaceúticas y conjugados de proteína de unión de las mismas
CL2012001836A1 (es) Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros.
IN2014MN02069A (es)
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
SV2010003581A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
CR20120596A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
BR112013013167A8 (pt) inibidores de bromodomínio e usos dos mesmos
MX2013004817A (es) Enfermedad inflamatoria.
DOP2012000279A (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona
MX381497B (es) Composiciones vacuna.
EP2617413A4 (en) NANIUM DERIVED FROM A TUMOR TISSUE AND CANCER VACCINE THEREFOR
ES2446643R1 (es) Composiciones farmacéuticas combinadas y su uso para preparar un medicamento destinado al tratamiento del vértigo, la cinetosis y la distonía vegetativa-vascular
MX2018008597A (es) Composiciones inyectables de melfalan que comprenden un derivado de ciclodextrina y metodos de fabricacion y uso de las mismas.
CR20120549A (es) Composiciones farmacèuticas que comprenden hidromorfona y naloxona
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
MX2013010367A (es) Composiciones y metodos para la terapia y diagnostico de influenza.
ECSP12011951A (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnóstico para una enfermedad parasitaria